InChI=1S/C32H31N3O5/c1-3-4-5-10-15-39-30(37)32(38)16-23-34-21-13-8-6-11-18(21)25-26-20(17-33-29(26)36)24-19-12-7-9-14-22(19)35(28(24)27(25)34)31(32,2)40-23/h6-9,11-14,23,38H,3-5,10,15-17H2,1-2H3,(H,33,36)/t23-,31+,32+/m0/s1 |
ZHEHVZXPFVXKEY-RUAOOFDTSA-N |
CCCCCCOC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cAMP-dependent protein kinase (EC 2.7.11.11).
|
|
View more via ChEBI Ontology
hexyl (5R,6S,8S)-6-hydroxy-5-methyl-13-oxo-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-6-carboxylate
|
(9R,10S,12S)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid hexyl ester
|
ChEBI
|
antibiotic KT 5720
|
ChEBI
|
KT-5720
|
ChemIDplus
|
KT5720
|
ChEBI
|
108068-98-0
|
CAS Registry Number
|
ChemIDplus
|
8376260
|
Reaxys Registry Number
|
Reaxys
|
12547730
|
PubMed citation
|
Europe PMC
|
15528235
|
PubMed citation
|
Europe PMC
|
16542724
|
PubMed citation
|
Europe PMC
|
20972940
|
PubMed citation
|
Europe PMC
|
21287607
|
PubMed citation
|
Europe PMC
|
23713946
|
PubMed citation
|
Europe PMC
|
7786606
|
PubMed citation
|
Europe PMC
|
7954419
|
PubMed citation
|
Europe PMC
|
8529881
|
PubMed citation
|
Europe PMC
|
9699505
|
PubMed citation
|
Europe PMC
|
9872566
|
PubMed citation
|
Europe PMC
|
|